Imperial College London

DrPhilipMolyneaux

Faculty of MedicineNational Heart & Lung Institute

Clinical Senior Lecturer in Interstitial Lung Disease
 
 
 
//

Contact

 

p.molyneaux

 
 
//

Location

 

Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Summary

Dr Philip Molyneaux is a Clinical Senior Lecturer in Interstitial lung disease and an Honorary Consultant at the Royal Brompton Hospital.

Philip qualified from Guy's, King's and St Thomas' School of Medicine in 2004, where he completed an intercalated BSc. in Molecular Genetics. He undertook his SHO training at Guy’s and St Thomas’ and upon completion of the MRCP attained an NIHR Academic Clinical Fellow position in Respiratory medicine at Imperial College. He spent the next two years training at St Mary’s Hospital and working with Professors Cookson, Moffatt and Johnston studying the respiratory microbiome in COPD. 

An Asmarley training fellowship allowed him to undertake a PhD examining the host response to the respiratory microbiome in Idiopathic Pulmonary Fibrosis as part of the Prospective Study of Fibrosis In the Lung Endpoints (PROFILE) study with Professors Maher, Cookson and Moffatt

Having completed his clinical training in Respiratory and Critical Care Medicine he returned to Imperial joining the Fibrosis Research Group as a Senior Clinical Lecturer. He also holds a position as Consultant in Interstitial Lung Disease at the Royal Brompton Hospital where he has a  special interest in Familial Pulmonary Fibrosis.

Publications

Journals

Macaluso C, Furcada JM, Alzaher O, et al., 2018, The Potential Impact of Azithromycin in Idiopathic Pulmonary Fibrosis., Eur Respir J

Visca D, Mori L, Tsipouri V, et al., 2018, Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label mixed-method, crossover randomised controlled trial, Lancet Respiratory Medicine, Vol:6, ISSN:2213-2600, Pages:759-770

Celada LJ, Kropski JA, Herazo-Maya JD, et al., 2018, PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production., Sci Transl Med, Vol:10

Sun J, Herazo-Maya JD, Molyneaux PL, et al., 2018, Regularized Latent Class Model for Joint Analysis of High Dimensional Longitudinal Biomarkers and A Time-to-Event Outcome., Biometrics

Mallia P, Webber J, Gill SK, et al., 2018, Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease, Journal of Allergy and Clinical Immunology, Vol:142, ISSN:0091-6749, Pages:815-+

More Publications